What is the latest KPL stock price?
The latest stored price for KPL is Rs 2,743.00 as of 2026-07-20.
gimli
KPL stock AI analysis
KPL Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
KWALITY PHARMACEUTICALS L is a small-cap stock in Healthcare. This Gimli page shows the latest available KPL price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹2,743.00
1W return
+3.32%
1M return
+10.37%
3M return
+64.98%
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
60.48
Turnover
₹4.57 cr
Why it can matter in screens
- Momentum: KPL is above 50DMA, below 200DMA; RSI is 60.48.
- Returns: 1D +1.52%, 1W +3.32%, 1M +10.37%, 3M +64.98%, 1Y n/a.
- Trend levels: 52W high ₹2,816.90, 52W low ₹1,579.55, off high -2.62%.
- Liquidity: latest turnover is ₹4.57 cr; volume vs 20D is +0.52%.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR -6.80%, 3Y profit CAGR -30.73%.
Quick Answers
Is KPL above its 50DMA and 200DMA?
KPL is above 50DMA, below 200DMA. The latest 50DMA is 2,349.09 and the latest 200DMA is n/a.
What are KPL PE, ROE and ROCE?
KPL has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.
How has KPL performed recently?
KPL has returned +10.37% over 1 month, +64.98% over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 158.17 cr | 39.82 cr | 25.31 cr | 24.39 |
| 2025-12-31 | 123.97 cr | 30.48 cr | 16.00 cr | 15.42 |
| 2025-09-30 | 111.95 cr | 26.25 cr | 14.12 cr | 13.60 |
| 2025-06-30 | 111.86 cr | 24.55 cr | 11.92 cr | 11.49 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 372.12 cr | 82.36 cr | 39.89 cr | 38.44 |
| 2024-03-31 | 309.00 cr | 61.36 cr | 23.98 cr | 23.11 |
| 2023-03-31 | 253.94 cr | 46.70 cr | 19.47 cr | 18.45 |
| 2022-03-31 | 459.64 cr | 175.24 cr | 120.05 cr | 115.36 |
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 469,405.90 cr | 40.823336 | +14.71% | +15.52% |
| DIVISLAB | DIVI S LABORATORIES LTD | 194,269.92 cr | 75.650281 | +16.19% | +8.71% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 169,405.46 cr | 78.319677 | +17.18% | +42.14% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,040.28 cr | 65.380043 | +21.03% | +21.93% |
| CIPLA | CIPLA LTD | 116,452.52 cr | 30.005339 | +11.79% | -2.75% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 115,616.29 cr | 23.056854 | +17.93% | +17.85% |
| LUPIN | LUPIN LIMITED | 113,320.96 cr | 21.221472 | +26.83% | +28.27% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 107,290.40 cr | 74.382732 | +14.33% | -9.32% |
Try these prompts
- Analyze KWALITY PHARMACEUTICALS L with valuation, momentum and industry peers
- Compare KPL with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare KPL with other Healthcare stocks
Data snapshot: 2026-07-20. Not investment advice.